The abstract is read at the publisher; the summary is JClub's.
NLRX1 is the only observed essential regulator of mitochondrial permeability transition pore activity, with NLRX1 deficiency abolishing calcium-induced opening and cyclosporine A sensitivity.
- Why it matters: The field lacks a universally accepted essential protein for mPTP opening, limiting mechanism-based confidence in mPTP-targeted cardioprotection for ischemia-reperfusion injury.
- What they did: Two independent laboratories converged on NLRX1 as a mitochondrially targeted innate immune receptor; they used NLRX1 deficiency to test mPTP opening, cyclosporine A sensitivity, and mitochondrial calcium release after cardiac I/R.
- The result: Bioinformatic searches linked absence of mPTP to absence of NLRX1 across species, and NLRX1-deficient hearts showed increased I/R injury at specific ischemia durations, challenging indiscriminate mPTP inhibition as universally protective.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.